These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6893926)

  • 1. [Pirenzepina as an inhibitor of gastric secretion (experimental research)].
    Di Mezza G; Turtur A; Visone C; Sannino A; Luppino E; Nutile T; Perri T; Montanino C
    Arch Sci Med (Torino); 1980; 137(1):45-60. PubMed ID: 6893926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cytoprotection by pirenzepine is not mediated by catecholamines.
    Martinotti E; Bernardini C; Del Tacca M; Pellegrini M; Soldani G; Bertelli A
    Acta Physiol Hung; 1984; 64(3-4):219-24. PubMed ID: 6549422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of gastric emptying and secretion by pirenzepine and atropine in rats.
    Scarpignato C; Girone MG; Tirelli F; Bertaccini G
    Eur J Pharmacol; 1984 Jun; 101(3-4):193-200. PubMed ID: 6547908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of pA2 values of pirenzepine and atropine for guinea-pig gastric fundus and gastric smooth muscle.
    Del Tacca M; Soldani G; Bernardini C; Martinotti E
    Pharmacology; 1984; 29(6):329-35. PubMed ID: 6150504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of pirenzepine (LS 519) on basal and pentagastrin-stimulated gastric acid secretion in normal persons].
    Galmiche JP; Lerebours E; Colin R
    Med Chir Dig; 1980; 9(4):331-4. PubMed ID: 6894012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytoprotective properties of pirenzepine, PGE2 and cimetidine in the rat].
    Del Soldato P
    Boll Chim Farm; 1981 Nov; 120(11):631-8. PubMed ID: 6122455
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of pirenzepine and atropine on the transmural gastric mucosal potential difference (author's transl)].
    von Kleist D; Staud R; Stopik D; Hampel HE
    Dtsch Z Verdau Stoffwechselkr; 1980; 40(3-4):110-4. PubMed ID: 6893819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gastric mucosa carbonic anhydrase by pirenzepine in patients with gastroduodenal ulcers.
    Puşcaş I; Búzás G; Surányi P; Domuta M
    Arzneimittelforschung; 1981; 31(3):508-9. PubMed ID: 6894381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirenzepine inhibits acid and pepsinogen secretion by the isolated perfused mouse stomach.
    Müller-Lissner SA; Szelenyi I; Engler H; Blum AL
    Scand J Gastroenterol Suppl; 1982; 72():101-3. PubMed ID: 6127794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.
    Konturek SJ; Obtulowicz W; Kwiecień N; Dobrzańska M; Swierczek J; Kopp B; Olesky J
    Scand J Gastroenterol Suppl; 1980; 66():63-9. PubMed ID: 6941379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirenzepine selectively inhibits gastric acid secretion: a comparative pharmacological study between pirenzepine and seven other antiacetylcholine drugs.
    Heathcote BV; Parry M
    Scand J Gastroenterol Suppl; 1980; 66():15-26. PubMed ID: 6113681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiulcerogenic effect of a pyrido-benzodiazepine derivative (L-S 519) on experimental ulcers.
    Kitagawa H; Kurahashi K; Fujiwara M; Kohei H
    Arzneimittelforschung; 1978; 28(11):2122-7. PubMed ID: 582916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
    Leitold M; Fleissig W; Merk A
    Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atropine and pirenzepine on healing of gastric ulcer induced by mucosal excision in rats.
    Sano M; Kitagawa H; Fujiwara M
    Clin Ther; 1985; 7(3):380-9. PubMed ID: 3838920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cytoprotection by pirenzepine: role of endogenous catecholamines.
    Bernardini C; Martinotti E; Del Tacca M; Soldani G; Bertelli A
    Int J Tissue React; 1984; 6(2):175-80. PubMed ID: 6547413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pirenzepine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers.
    Jaup BH; Dotevall G
    Scand J Gastroenterol; 1981; 16(6):769-73. PubMed ID: 6119766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer.
    Matsuo Y; Seki A
    Arzneimittelforschung; 1979; 29(7):1028-35. PubMed ID: 582994
    [No Abstract]   [Full Text] [Related]  

  • 18. [MI cholinergic receptors of gastric secretion: current status].
    Vatier J
    J Pharmacol; 1985; 16 Suppl 2():145-69. PubMed ID: 2867250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection by PGE2, atropine, pirenzepine and vagotomy in rats.
    Rovati V; Foschi D; Ferrante F; Del Soldato P; Daniotti S; Varin L
    Scand J Gastroenterol Suppl; 1982; 72():261-4. PubMed ID: 6957994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of pirenzepine and atropine on gastric acid secretion, salivary secretion and pupil diameter in the rat.
    Parry M; Heathcote BV
    Life Sci; 1982 Oct; 31(14):1465-71. PubMed ID: 6897277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.